Community Trust & Investment Co. Trims Stake in UnitedHealth Group Inc (NYSE:UNH)

Community Trust & Investment Co. lessened its holdings in UnitedHealth Group Inc (NYSE:UNH) by 2.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 105,360 shares of the healthcare conglomerate’s stock after selling 2,181 shares during the period. UnitedHealth Group makes up about 2.7% of Community Trust & Investment Co.’s investment portfolio, making the stock its 8th largest position. Community Trust & Investment Co.’s holdings in UnitedHealth Group were worth $22,897,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. Rockland Trust Co. increased its position in UnitedHealth Group by 37.4% during the third quarter. Rockland Trust Co. now owns 6,596 shares of the healthcare conglomerate’s stock valued at $1,420,000 after acquiring an additional 1,795 shares during the last quarter. Intellectus Partners LLC increased its position in UnitedHealth Group by 29.3% during the third quarter. Intellectus Partners LLC now owns 2,711 shares of the healthcare conglomerate’s stock valued at $589,000 after acquiring an additional 615 shares during the last quarter. Affiance Financial LLC increased its position in UnitedHealth Group by 15.2% during the third quarter. Affiance Financial LLC now owns 4,064 shares of the healthcare conglomerate’s stock valued at $883,000 after acquiring an additional 537 shares during the last quarter. Buffington Mohr McNeal increased its position in UnitedHealth Group by 4.6% during the third quarter. Buffington Mohr McNeal now owns 3,085 shares of the healthcare conglomerate’s stock valued at $670,000 after acquiring an additional 136 shares during the last quarter. Finally, Townsend & Associates Inc increased its position in UnitedHealth Group by 10.5% during the third quarter. Townsend & Associates Inc now owns 5,567 shares of the healthcare conglomerate’s stock valued at $1,225,000 after acquiring an additional 530 shares during the last quarter. Institutional investors own 85.66% of the company’s stock.

In related news, Director Richard T. Burke sold 2,000 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $231.50, for a total value of $463,000.00. Following the completion of the sale, the director now directly owns 187,979 shares of the company’s stock, valued at $43,517,138.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 12,000 shares of the company’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the sale, the director now directly owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 24,000 shares of company stock valued at $5,924,120. 0.87% of the stock is owned by insiders.

A number of research firms have weighed in on UNH. Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. BMO Capital Markets cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $292.00 to $249.00 in a research report on Monday, September 30th. Royal Bank of Canada set a $311.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Cantor Fitzgerald set a $310.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, Morgan Stanley cut their price objective on shares of UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating on the stock in a research report on Thursday, September 26th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $283.78.

Shares of UNH traded up $2.89 during trading hours on Friday, reaching $226.62. 121,292 shares of the company traded hands, compared to its average volume of 4,519,363. The firm has a market cap of $208.59 billion, a price-to-earnings ratio of 17.52, a PEG ratio of 1.17 and a beta of 0.60. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62. The stock’s fifty day moving average price is $227.48 and its 200 day moving average price is $240.20.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.46 by $0.14. The firm had revenue of $60.60 billion during the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm earned $3.14 earnings per share. On average, research analysts forecast that UnitedHealth Group Inc will post 14.83 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date of this dividend was Friday, September 13th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Risk Tolerance and Your Investment Decisions

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.